Society produces guidance for pharmacists on OTC omeprazole
Practice guidance for pharmacists on the over-the-counter supply of omeprazole has been published by the Royal Pharmaceutical Society's practice division following the reclassification of omeprazole 10mg from prescription-only to pharmacy medicine status.
The practice guidance highlights the main points to consider when counter
prescribing omeprazole, which is indicated for the relief of heartburn
symptoms associated with acid reflux in adults aged 18 and over. The
guidance provides information on when omeprazole is appropriate for OTC
supply and when patients should be referred to a GP. It explains how
omeprazole works and how to recognise that the symptoms described are
those of heartburn associated with gastro-oesophageal reflux. It also
gives information on how the tablets should be taken and on cautions,
adverse effects and interactions.
Sue Kilby, the Society’s head of practice, said: “Heartburn
is a common condition that may be extremely unpleasant for the sufferer.
It is thought to be experienced by around 40 per cent of adults at some
time and to account for one in 20 GP consultations. Community pharmacists,
with their skills and knowledge, are in an ideal position to assess people
when they are complaining of symptoms of heartburn and for most remove
the need of a GP consultation. The pharmacist is able to make recommendations
on treatment, provide counselling and information on life style changes
which all helps heartburn suffers to receive prompt, appropriate care,
which is easily accessible.”
The guidance may be downloaded in PDF format from the Society’s
website.
Copies may also be obtained from Lorraine Fearon, Practice Division,
Royal Pharmaceutical Society, 1 Lambeth High
Street, London SE1 7JN (tel 020 7572 2409).
|
The
Pharmaceutical Journal